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Abstract: Importance: Despite the high prevalence, evidence-based treatments for abuse-related post-
traumatic stress disorder (PTSD) in adolescents have rarely been studied. Objective: To examine whether
developmentally adapted cognitive processing therapy (D-CPT) is more effective than a wait-list condi-
tion with treatment advice (WL/TA) among adolescents with PTSD related to childhood abuse. Design,
Setting, and Participants: This rater-blinded, multicenter, randomized clinical trial (stratified by center)
enrolled treatment-seeking adolescents and young adults (aged 14-21 years) with childhood abuse-related
PTSD at 3 university outpatient clinics in Germany from July 2013 to June 2015, with the last follow-up
interview conducted by May 2016. Of 194 patients, 88 were eligible for randomization. Interventions:
Participants received D-CPT or WL/TA. Cognitive processing therapy was enhanced by a motivational
and alliance-building phase, by including emotion regulation and consideration of typical developmental
tasks, and by higher session frequency in the trauma-focused core CPT phase. In WL/TA, participants
received treatment advice with respective recommendations of clinicians and were offered D-CPT after
7 months. Main Outcomes and Measures: All outcomes were assessed before treatment (baseline), ap-
proximately 8 weeks after the start of treatment, after the end of treatment (posttreatment), and at the
3-month follow-up. The primary outcome, PTSD symptom severity, was assessed in clinical interview
(Clinician-Administered PTSD Scale for Children and Adolescents for DSM-IV [CAPS-CA]). Secondary
outcomes were self-reported PTSD severity, depression, borderline symptoms, behavior problems, and
dissociation. Results: The 88 participants (75 [85%] female) had a mean age of 18.1 years (95% CI,
17.6-18.6 years). In the intention-to-treat analysis, the 44 participants receiving D-CPT (39 [89%] fe-
male) demonstrated greater improvement than the 44 WL/TA participants (36 [82%] female) in terms
of PTSD severity (mean CAPS-CA scores, 24.7 [95% CI, 16.6-32.7] vs 47.5 [95% CI, 37.9-57.1]; Hedges
g = 0.90). This difference was maintained through the follow-up (mean CAPS-CA scores, 25.9 [95%
CI, 16.2-35.6] vs 47.3 [95% CI, 37.8-56.8]; Hedges g = 0.80). Treatment success was greatest during the
trauma-focused core phase. The D-CPT participants also showed greater and stable improvement in all
secondary outcomes, with between-groups effect sizes ranging from 0.65 to 1.08 at the posttreatment
assessment (eg, for borderline symptoms, 14.1 [95% CI, 8.0-20.2] vs 32.0 [95% CI, 23.8-40.2]; Hedges g
= 0.91). Conclusions and Relevance: Adolescents and young adults with abuse-related PTSD benefited
more from D-CPT than from WL/TA. Treatment success was stable at the follow-up and generalized to
borderline symptoms and other comorbidities.
DOI: https://doi.org/10.1001/jamapsychiatry.2018.4349





Rosner, Rita; Rimane, Eline; Frick, Ulrich; Gutermann, Jana; Hagl, Maria; Renneberg, Babette; Schreiber,
Franziska; Vogel, Anna; Steil, Regina (2019). Effect of Developmentally Adapted Cognitive Processing
Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Phys-






A Randomized Clinical Trial
Rita Rosner, DPhil; Eline Rimane, Dipl-Psych; Ulrich Frick, Dr Rer Biol-Hum; Jana Gutermann, Dr Rer Nat; Maria Hagl, DPhil;
Babette Renneberg, Dr Rer Nat; Franziska Schreiber, Dr Phil Nat; Anna Vogel, Dipl-Psych; Regina Steil, Dr Rer Nat
IMPORTANCE Despite the high prevalence, evidence-based treatments for abuse-related
posttraumatic stress disorder (PTSD) in adolescents have rarely been studied.
OBJECTIVE To examine whether developmentally adapted cognitive processing therapy
(D-CPT) is more effective than a wait-list condition with treatment advice (WL/TA) among
adolescents with PTSD related to childhood abuse.
DESIGN, SETTING, AND PARTICIPANTS This rater-blinded,multicenter, randomized clinical trial
(stratified by center) enrolled treatment-seeking adolescents and young adults (aged 14-21
years) with childhood abuse–related PTSD at 3 university outpatient clinics in Germany from
July 2013 to June 2015, with the last follow-up interview conducted byMay 2016. Of 194
patients, 88 were eligible for randomization.
INTERVENTIONS Participants received D-CPT orWL/TA. Cognitive processing therapy was
enhanced by amotivational and alliance-building phase, by including emotion regulation and
consideration of typical developmental tasks, and by higher session frequency in the
trauma-focused core CPT phase. InWL/TA, participants received treatment advice with
respective recommendations of clinicians and were offered D-CPT after 7 months.
MAIN OUTCOMES ANDMEASURES All outcomeswere assessed before treatment (baseline),
approximately 8 weeks after the start of treatment, after the end of treatment
(posttreatment), and at the 3-month follow-up. The primary outcome, PTSD symptom
severity, was assessed in clinical interview (Clinician-Administered PTSD Scale for Children
and Adolescents for DSM-IV [CAPS-CA]). Secondary outcomes were self-reported PTSD
severity, depression, borderline symptoms, behavior problems, and dissociation.
RESULTS The 88 participants (75 [85%] female) had amean age of 18.1 years (95%CI, 17.6-18.6
years). In the intention-to-treat analysis, the 44 participants receiving D-CPT (39 [89%] female)
demonstrated greater improvement than the 44WL/TA participants (36 [82%] female) in
terms of PTSD severity (mean CAPS-CA scores, 24.7 [95%CI, 16.6-32.7] vs 47.5 [95%CI,
37.9-57.1]; Hedges g = 0.90). This differencewasmaintained through the follow-up (mean
CAPS-CA scores, 25.9 [95%CI, 16.2-35.6] vs 47.3 [95%CI, 37.8-56.8]; Hedges g = 0.80).
Treatment successwas greatest during the trauma-focused core phase. The D-CPT participants
also showed greater and stable improvement in all secondary outcomes, with between-groups
effect sizes ranging from0.65 to 1.08 at the posttreatment assessment (eg, for borderline
symptoms, 14.1 [95%CI, 8.0-20.2] vs 32.0 [95%CI, 23.8-40.2]; Hedges g =0.91).
CONCLUSIONS AND RELEVANCE Adolescents and young adults with abuse-related PTSD
benefitedmore fromD-CPT than fromWL/TA. Treatment success was stable at the follow-up
and generalized to borderline symptoms and other comorbidities.
TRIAL REGISTRATION German Clinical Trials Register identifier: DRKS00004787
JAMA Psychiatry. 2019;76(5):484-491. doi:10.1001/jamapsychiatry.2018.4349
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N
umerous studies document the high prevalence of
child sexual and/or physical abuse and its detrimen-
tal consequences for mental health.1,2 In particular,
child sexual abuse is not only related to posttraumatic stress
disorder (PTSD) but to depression, anxiety, suicide attempts,
substance use, sexual risk-taking, health problems, and wel-
fare dependence in adulthood.3,4 The probability of PTSD is
especially high, with prevalence rates in adolescents ranging
from 31% for physical abuse to 41% for rape.5
Cognitiveprocessing therapy (CPT)6,7 is oneof themostex-
tensively studied treatments for adult PTSD.Meta-analyses8,9
indicate that cognitive interventions yield large effect sizes.
Until the present, CPT has rarely been tested in traumatized
youth andhas not been adapted to the specific needs of young
people with a history of abuse.
Recentmeta-analyses of PTSD treatment in youth10-12 re-
ported large overall effect sizes when compared with a wait-
list condition or no treatment (eg, Hedges g = 0.89) andmod-
erate effect sizes when compared with treatment as usual or
active control conditions (Hedges g = 0.45).11Results for con-
trolled outcomes focusing exclusively on child sexual and/or
physicalabuse–relatedsymptomsinadolescentsarestill scarce.
To our knowledge, only 1 randomized clinical trial (RCT) spe-
cifically targeted adolescents with PTSD after child sexual
abuse; Foa and colleagues13 found greater improvement in
PTSDsymptomseverityandseveral secondaryoutcomeswhen
comparing prolonged exposure with supportive counseling
in 61 adolescent girls.
In a previous uncontrolled pilot study, Matulis et al14
adapted CPT to adolescents with child sexual and/or physical
abuse–related PTSD (developmentally adapted CPT [D-CPT])
and successfully evaluated its effects. We therefore hypoth-
esizedthatD-CPTwouldbesuperior toawait-listconditionwith
treatment advice (WL/TA) at posttreatment and 3-month
follow-upassessments in reducing interviewer-assessedPTSD
severity, self-reported PTSD severity, depression, dissociative
experiences, borderline symptoms, and behavior problems.
Methods
Moredetails on this open rater-blinded,multicenter, 2-armed
RCT with 4 major assessment points (for D-CPT, at baseline,
after emotion regulation, posttreatment, and 3 months after
the end of treatment; for WL/TA, at baseline and 2, 4, and 7
months after baseline) can be found in the study protocol in
Supplement 1.15 The study was approved by the institutional
review boards of Catholic University Eichstätt-Ingolstadt,
Eichstätt, Germany; the Freie Universitaet of Berlin, Berlin,
Germany; and theGoetheUniversity Frankfurt, Frankfurt am
Main,Germany.Written informed consentwas obtained from
all participants and from parents or guardians of minors.
Participants
Participants were adolescents and young adults (aged 14-21
years) seeking treatment at 3 university outpatient clinics in
GermanyandenrolledfromJuly23,2013, throughJune17,2015.
A primary diagnosis of child sexual and/or physical abuse–
relatedPTSDwas required for inclusion. In lightof theongoing
discussion on diagnostic criteria for PTSD in children and
adolescents,16 thediagnostic threshold forPTSDdiagnosiswas
lowered; participants had to present a minimum of 2 avoid-
ance symptoms in the clinical interview instead of the 3 de-
fined in the DSM-IV-TR.17 Moreover, to be included, partici-
pants had to have sufficient German language skills, had to be
receiving no or stable psychopharmacologicalmedication (for
≥3 weeks), and had to have stable living conditions (ie, no
ongoing abuse and not homeless). Exclusion criteriawere cur-
rent severe suicidality or severe and life-threatening suicidal-
ity or self-harming behavior within the last 6months, an IQ of
75or less,and/oranydocumentedpervasivedevelopmentaldis-
order, concurrent psychotherapy, and the following diagnoses
according toDSM-IV-TR: lifetimepsychotic or bipolar disorder
(unclear cases were included), current substance dependence
(abstinence <6months), or a substance-induced disorder.
Procedure
Sample size estimations controlled for type I error to 5%with
statistical power of 0.8. ForWL/TA, we estimated baseline to
posttreatment effect sizes of Cohen d = 0.3 based on the ef-
fect sizes available then for supportive interventions.18Abase-
line to posttreatment Cohen d effect size of 0.9was assumed
for D-CPT.19 Not accounting for attrition, 2 groups of 45 par-
ticipants were required for the trial.
Participants were recruited through referrals from thera-
pists, psychiatric clinics, or youthwelfare institutions as well
as flyers and press releases. Potential participants underwent
screening using a self-report measure of PTSD. Adolescents
who met immediately checkable inclusion criteria were in-
vited for further baseline assessment. At this point, informed
consentwas obtained from themand—in the case ofminors—
fromtheirparentsor legal guardians.For randomization, study
coordinators received individual allocations per automated
email toensureallocationconcealment (the randomization list
was generated independently with SAS/STAT software [ver-
sion9.3; SAS Institute Inc] following a simple randomdesign,
stratified by study center).
Key Points
Question Is developmentally adapted cognitive processing
therapymore effective than a wait-list condition with treatment
advice in adolescents and young adults with posttraumatic stress
disorder related to childhood sexual and/or physical abuse?
Findings In a multicenter, randomized clinical trial of 88
participants (aged 14-21 years), developmentally adapted
cognitive processing therapy resulted in greater improvement in
blinded, rater-assessed posttraumatic stress disorder severity and
in self-reported secondary outcomes than a wait-list condition
with treatment advice. Treatment success was greatest during
the trauma-focused core phase and remained stable to the
3-month follow-up.
Meaning Developmentally adapted cognitive processing therapy
is more effective than a wait-list condition with treatment advice
and well tolerated in adolescents and young adults with
abuse-related posttraumatic stress disorder.
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Assessment
Interviewers blinded to treatment condition administered all
measures at separate appointments, includinga checklist con-
cerning serious adverse events. To improve reliability, inter-
viewer training included the rating of training videospresent-
ing criterion B of the Clinician-Administered PTSD Scale for
Children andAdolescents forDSM-IV (CAPS-CA),which inter-
viewers found the most difficult, and 2 frequently occurring
diagnoses from the Structured Clinical Interview for DSM-IV
(SCID), sections A and F (major depressive episode and social
phobia). Participants each received €20 (US $23) for attend-
ing themidtreatment andposttreatment assessments and€30
(US $35) for attending the follow-up assessment.
Primary Outcome
SeverityofPTSDwasmeasuredat eachassessmentpointusing
the CAPS-CA.20,21 This structured clinical interview rates fre-
quency and intensity of PTSD symptoms on a scale ranging
from 0 (never/no problem) to 4 (most of the time/extreme),
with a total score ranging from 0 to 136.
Secondary Outcomes
A self-rating of PTSD symptoms was obtained weekly during
D-CPT and at every assessment point using the University of
California at Los Angeles Post-traumatic Stress Disorder
Reaction Index (UCLA-PTSD-RI22,23; range, 0-68,with higher
scores indicating greater severity of symptoms). At the pre-
treatment and posttreatment assessments and at follow-up,
comorbiditywas assessedusing the SCID-I24 andSCID-II,25,26
borderlinepersonalitydisorderonly,26complementedbyparts
of the Diagnostic Interview for Mental Disorders in Child-
hood and Adolescence27 and the nicotine section of the
Expert System for Diagnosing Mental Disorders.28 Further
secondary outcomes that were assessed were the following:
• Beck Depression Inventory29,30 (range, 0-63, with higher
scores indicating greater severity of symptoms)
• BorderlineSymptomList2331 (range,0-92,withhigher scores
indicating greater severity of symptoms)
• Youth Self-report32,33 (range, 0-202, with higher scores
indicating greater severity of symptoms)
• AdolescentDissociativeExperiencesScale34,35 (range,0-300,
with higher scores indicating greater severity of symptoms)
Additionalexploratoryvariablesnotpresentedhereinaregiven
in the study protocol in Supplement 1.15
Treatments
Treatment was delivered by 14 master-level or postdoctoral
therapists (including J.G.; 10 female), with 10 licensed psy-
chotherapists and4 in training. Therapists had amean (SD) of
46.1 (19.3) months of clinical experience, with 3.3 (5.6) cases
of PTSD. All therapists treated 1 training case to familiarize
themselves with D-CPT before entering the trial.




were invited to a joint biweekly telephone case consultation.
Therapeutic adherence and therapeutic competence in D-CPT
wereassessedby2trainedraters (J.G.andF.S.).Results reflected
goodtherapeuticadherenceandcompetence(basedon2sessions
per case) (eMethods in Supplement 2).
We adapted CPT to the needs of adolescents and young
adults after sexual and/or physical abuseby (1) beginningwith
a commitment phase to enhance treatment motivation and
therapeutic alliance and to establish the formal framework for
administering therapy; (2) integrating emotion management
techniques36,37 early inD-CPT; (3) increasing treatment inten-
sity by administering the middle part of the therapeutic pro-
tocol (ie, actualCPT)at ahigh frequency (approximately 15 ses-
sions in 4 weeks) to address the fluctuating motivation in
adolescents38; and (4) giving special consideration to devel-
opmental tasks, such as career choice and romantic relation-
ships, because adolescent patients are at risk of dropping out
of school, starting relationshipswithabusivepartners, orbeing
abusedagain.Altogether,D-CPTwas tobe completed in thirty
50-minute sessions (with 6 optional sessions, eg,with a care-
giver or for crisis intervention) in 16 to 20 weeks (eTable 1 in
Supplement 2).More on the rationale for adaptingCPT canbe
found in Matulis et al.14
Participants inWL/TAwereadvised to seek treatmentout-
side the trial. In line with suggestions of the institutional re-
viewboards,D-CPTwasoffered to theseparticipants after the
3-month follow-up. For standardization,wedeveloped a pro-
tocol for how study coordinators should instruct participants
to find a psychotherapist. Because treatment costs in
Germany are covered by health insurance, psychotherapy
wasaccessible to eachparticipant. Interventions in theWL/TA
group were recorded in detail.
Statistical Analysis
Follow-upwas completed byMay 31, 2016, and datawere ana-
lyzed according to the intention-to-treat approach. Before
Figure 1. CONSORTDiagram of Participant Flow
194 Participants assessed for eligibility
106 Excluded
42 Did not meet inclusion
criteria
36 No informed consent
28 Met exclusion criteria
88 Randomized





36 Completed 3-mo follow-up
assessment
29 Completed 3-mo follow-up
assessment
44 Included in ITT analysis 44 Included in ITT analysis
D-CPT indicates developmentally adapted cognitive processing therapy;
ITT, intention-to-treat; andWL/TA, wait-list/treatment advice.
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unblinding, the original analysis planwas adapted tomore so-
phisticated missing value treatment (eMethods in Supple-
ment 2). Statistical analysis was performed in the following 3
steps. First, potential sampling bias due to dropout was scru-
tinized by pattern mixture models classifying participants ac-
cording to their pattern of missing values for the 4 major as-
sessment points (baseline, midtreatment, posttreatment, and
follow-up).Nohintofselectionbiaswasfound.Second,themain
study hypothesis was evaluated using a random-coefficient
model,with timeaspiecewise level 1 regressorvariableswithin
participants (level 2), to allow for nonlinear shapes of thera-
peutic progress (see also Foa and colleagues13 for this ap-
proach). Eachparticipant contributed4or fewer records to the
dataset.Calculations forpatternmixturemodelswereachieved
by SAS Proc Mixed (version 9.3; SAS Institute Inc). Piecewise
hierarchicalmodelingwasperformedusingHLMsoftware (ver-
sion 7.03; Scientific Software International, Inc) growth curve
modeling. Third, we calculated effect sizes for differences be-
tweenWL/TA andD-CPT groups by performing the respective
contrast 2-tailed,unpaired t testsbetweengroups (atmidtreat-
ment,posttreatment, and follow-upassessmentsusingHedges
g) or separately for both groups (baseline vs later measure-
ments using Cohen d).
Results
A total of 88 participants (75 female [85%] and 13male [15%];
mean age, 18.1 years [95% CI, 17.6-18.6 years]) were enrolled
from July 23, 2013, through June 17, 2015 (Figure 1). Partici-
pants in the D-CPT group attended a mean (SD) of 25.4 (11.6)
sessions (range,0-36); completers attendedamean (SD)of 31.6
(3.3) sessions (range, 19-36). Early completion of D-CPT re-
quired the therapist and patient to agree that treatment aims
had been reached. Two D-CPT participants dropped out be-
fore the first therapy session, 2during the commitmentphase,
5 during emotion regulation phase, and 3 during the core CPT
phase. Of the 12 D-CPT dropouts (27%), 5 had been errone-
ously randomized (eg, having substance dependence re-
vealed later or having invented the trauma) andwere offered
alternative treatment or referral. In terms of primary out-
come, 8 D-CPT participantsmissed themidtreatment assess-
ment and 15 missed the posttreatment and follow-up assess-
ments. In theWL/TAgroup,24participants receivedno further
treatment (55%; some of them waiting to be admitted to
D-CPT), and 12 received some kind of psychosocial support
and/orpsychologicalorpsychiatric treatment (27%),with8par-
ticipants reporting that the traumawas addressed. In termsof
primary outcome, 8 WL/TA participants (18%) did not com-
plete theposttreatment and/or follow-upassessment. The last
follow-up interview was conducted by May 31, 2016.
Table 1containsdemographicdata,andTable2givessymp-
tomscores.No significant differences between theD-CPTand
WL/TA groups at baseline (no adjustment for type I error risk
inflation), except for higher WL/TA scores for dissociation
(mean Adolescent Dissociative Experiences Scale scores,
99.3 [95% CI, 82.1-116.4] vs 75.4 [95% CI, 59.1-91.7]) and
prevalence of nicotine dependence (22 [50%] vs 11
[25%]), occurred.
Primary Outcome
Including all participants undergoingmeasurement at the re-
spective time point yielded the mean CAPS-CA scores indi-
cated in Table 2 (see also Figure 2). Themidtreatment assess-
mentwas reachedafter amean (SD) of 83 (27) days fromstudy
entry; posttreatment assessment, 173 (42) days; and
follow-up assessment, 261 (49) days.We found no significant
differences between conditions.
Both groups showed a significant reduction in PTSD
symptom severity (CAPS-CA) between study entry and
the posttreatment assessment (D-CPT: t28 = 9.87 [P < .001;
Cohend = 1.83];WL/TA: t35 = 6.10 [P < .001; Cohend = 1.02]).










Age, mean (95% CI), y 18.1 (17.6-18.6) 18.2 (17.5-18.8) 18.1 (17.4-18.7) .82b
Female, No. (%) 75 (85) 39 (89) 36 (82) .37c
Immigration background, No. (%) 23 (26) 13 (30) 10 (23) .47c
Subthreshold PTSD, No. (%)d 11 (12) 5 (11) 6 (14) .75c
Comorbid DSM-IV disorders, No. (%)e
0 18 (20) 10 (23) 8 (18) .60c
1 or 2 41 (47) 23 (52) 18 (41) .28c
≥3 29 (33) 11 (25) 18 (41) .11c
Most frequent DSM-IV disorders, No. (%)
Mood disorders 44 (50) 21 (48) 23 (52) .67c
Anxiety disorders 35 (40) 14 (32) 21 (48) .13c
Nicotine dependence 33 (38) 11 (25) 22 (50) .02c
Borderline personality disorder 14 (16) 5 (11) 9 (20) .24c
No. of suicide attempts before treatment,
mean (95% CI)
1.0 (0.4-1.6) 0.7 (0.3-1.5) 1.3 (0.5-2.4) .35b
Out-of-home placement or institutional
care, No. (%)








2-sided unpaired t test.
c Calculated from Pearson χ2 test.
dSubthreshold PTSDwas defined as
having 2 avoidance symptoms (all
else according to DSM-IV-TR).
e Includes nicotine dependence and
borderline personality disorder.
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However, D-CPT resulted in a considerably better outcome in
comparison with WL/TA (mean CAPS-CA score at posttreat-
mentassessment,24.7 [95%CI, 16.6-32.7]vs47.5 [95%CI, 37.9-
57.1]; between-groupsHedges g = 0.90) (Table2). Between the
posttreatment and follow-up assessments, treatment gains
were stable, with the advantage for D-CPTmaintained (mean
CAPS-CA scores at 3-month follow-up, 25.9 [95% CI, 16.2-
35.6] vs 47.3 [95% CI, 37.8-56.8]; Hedges g = 0.80).
Piecewise regression analysis permits a more fine-
grained inspection (Table3). Starting fromindividual initial lev-
els of symptom load (β00), a slightuniformreductionof symp-
tom load of 0.07 points per day (β10) occurred to the
midtreatment assessment. After the midtreatment assess-
ment, which marks the beginning of the CPT phase in the
D-CPT condition, both groups showed larger reductions (β20)
in individual shapes,but inD-CPTthisgeneraleffectwasnearly
doubled (β21). Between the posttreatment and follow-up
assessments, a further individually varying improvementwas
observed among both groups (β30), but againwith clear supe-
riority of D-CPT (β31). The final regressionmodel was not im-
provedbyadjusting for potentially confoundingeffects (treat-
ment center, age, sex, and pattern of missing values).
Table 2. Primary and Secondary Outcomes at All Assessment Points
Assessment Point





















Baseline 88 65.6 (60.9-70.3) 44 65.6 (58.5-72.8) 44 65.5 (59.2-71.9) 0.00
Midtreatment 77 57.0 (51.2-62.8) 36 56.9 (48.8-65.0) 41 57.2 (48.6-65.8) 0.01
Posttreatment 65 37.3 (30.4-44.2) 29 24.7 (16.6-32.7) 36 47.5 (37.9-57.1) 0.90
3-mo Follow-up 65 37.8 (30.6-44.9) 29 25.9 (16.2-35.6) 36 47.3 (37.8-56.8) 0.80
Clinically relevant response, No. (%)
Posttreatment 65 14 (22) 29 11 (38) 36 3 (8) NA
3-mo Follow-up 65 14 (22) 29 11 (38) 36 3 (8) NA
Secondary Outcomes
Self-reported PTSD, UCLA-PTSD-RIb
Baseline 88 42.2 (39.6-44.8) 44 41.2 (37.8-44.6) 44 43.2 (39.2-47.2) 0.17
Posttreatment 59 27.3 (22.7-32.0) 27 18.1 (12.4-23.8) 32 35.1 (29.0-41.2) 1.08
3-mo Follow-up 60 27.8 (23.2-32.4) 25 16.1 (9.8-22.4) 35 36.1 (31.1-41.1) 1.35
Depression, BDI-IIc
Baseline 86 28.8 (25.9-31.6) 44 27.5 (23.7-31.2) 42 30.1 (25.6-34.6) 0.20
Posttreatment 60 19.7 (15.9-23.5) 28 12.8 (8.0-17.6) 32 25.8 (20.7-30.9) 0.98
3-mo Follow-up 59 18.8 (14.5-23.1) 25 11.6 (5.6-17.6) 34 24.1 (18.5-29.6) 0.81
Borderline symptom severity, BSL-23d
Baseline 87 38.0 (33.3-42.8) 44 35.8 (29.4-42.2) 43 40.3 (33.1-47.5) 0.20
Posttreatment 59 23.8 (18.2-29.4) 27 14.1 (8.0-20.2) 32 32.0 (23.8-40.2) 0.91
3-mo Follow-up 60 23.3 (17.6-29.0) 25 14.4 (5.6-23.1) 35 29.7 (22.7-36.8) 0.74
Behavior problems, YSRe
Baseline 86 69.7 (64.8-74.5) 44 66.7 (61.0-72.4) 42 72.8 (64.8-80.8) 0.27
Posttreatment 60 53.2 (46.0-60.4) 28 40.1 (30.2-50.1) 32 64.6 (55.7-73.6) 0.97
3-mo Follow-up 60 48.7 (41.7-55.7) 25 34.7 (24.4-44.9) 35 58.7 (50.4-67.1) 1.00
Dissociation, A-DESf
Baseline 87 87.2 (75.3-99.1) 44 75.4 (59.1-91.7) 43 99.3 (82.1-116.4) 0.44
Posttreatment 60 60.4 (47.1-73.6) 28 43.4 (25.6-61.1) 32 75.2 (56.6-93.8) 0.65
3-mo Follow-up 60 53.2 (39.7-66.7) 25 27.5 (13.1-42.0) 35 71.6 (52.6-90.6) 0.92
Abbreviations: A-DES, Adolescent Dissociative Experiences Scale;
BDI-II, Beck Depression Inventory–II; BSL-23, Borderline Symptom List 23;
CAPS-CA, Clinician-Administered PTSD Scale for Children and Adolescents for
DSM-IV; D-CPT, developmentally adapted cognitive processing therapy; NA, not
applicable; PTSD, posttraumatic stress disorder; UCLA-PTSD-RI, University of
California at Los Angeles Post-traumatic Stress Disorder Reaction Index;
WL/TA, wait-list/treatment advice; YSR, Youth Self-report.
a Scores range from0 to 136, with higher scores indicating greater severity
of symptoms.
bScores range from0 to 68, with higher scores indicating greater severity
of symptoms.
c Scores range from0 to 63, with higher scores indicating greater severity
of symptoms.
dScores range from0 to 92, with higher scores indicating greater severity
of symptoms.
e Scores range from0 to 202, with higher scores indicating greater severity
of symptoms.
f Scores range from0 to 300, with higher scores indicating greater severity
of symptoms.
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To permit comparison with published studies on adoles-
cents, additional analyseswereperformedbyage, splitting the
sample into the following 2 groups: younger than 18 years
(n = 40) and 18 years or older (n = 48). The results were simi-
lar, althoughyoungerparticipants seemed toprofitmore from
D-CPT (eTable 2 in Supplement 2).
Secondary Outcomes
Self-reported PTSD symptom severity (UCLA-PTSD-RI score)
corresponded with the results from blinded, interview-rated
PTSD assessment, displaying the same pattern of improve-
ment but with somewhat larger between-groups effect sizes
at the posttreatment (mean scores, 18.1 [95%CI, 12.4-23.8] vs
35.1 [95%CI, 29.0-41.2];Hedges g = 1.08) and follow-up (mean
scores, 16.1 [95%CI,9.8-22.4]vs36.1 [95%CI,31.1-41.1];Hedges
g = 1.35) assessments. Also, participants in both groups im-
proved significantly from pretreatment to posttreatment as-
sessments in all other secondary outcomes, but again D-CPT
resulted in more and stable treatment gains, with between-
groups effect sizes ranging from0.65 forAdolescentDissocia-
tive Experiences Scale (mean scores, 43.4 [95% CI, 25.6-61.1]
vs 75.2 [95% CI, 56.6-93.8]) to 0.98 for Beck Depression
Inventory–II (meanscores, 12.8 [95%CI, 8.0-17.6] vs25.8 [95%
CI, 20.7-30.9]) at the posttreatment assessment and 0.74 for
the Borderline Symptom List 23 (mean scores, 14.4 [95% CI,
5.6-23.1] vs 29.7 [95% CI, 22.7-36.8]) to 1.00 for Youth Self-
report (mean scores, 34.7 [95%CI, 24.4-44.9] vs 58.7 [95%CI,
50.4-67.1]) at the follow-up assessment (Table 2).
Clinically Relevant Response
A clinically relevant or good response was defined as an im-
provement of at least 2 SD39 below baseline in interview-
rated PTSD scores (CAPS-CA) at the posttreatment and/or
follow-upassessments.Altogether, 15participants in theD-CPT
group(34%of the intention-to-treat subsample) showedagood
response as opposed to 4 inWL/TA (9%) (χ2 = 12.26; P < .001
[n = 69]) (for details, see Table 2). Twenty participants could
not improve this much per definition because they started
treatment with scores below the cutoff of 2 SD. No clinically
relevant worsening of symptoms was observed.
In terms of rater-based serious adverse event assessment
according to the International Council for Harmonization
Guideline forGoodClinical Practice,40 1D-CPTparticipantwas
admitted to thehospital (for a somatic reasonunrelated to the
study)vs6WL/TAparticipants.AnotherD-CPTparticipantwas
admitted to inpatient psychiatric treatment vs 6 WL/TA par-
ticipants.OneWL/TAparticipantattemptedsuicide. In11cases,
data were missing at the midtreatment assessment and in 23
cases at the posttreatment assessment.
Discussion
In thismulticenterRCTwith88adolescents andyoungadults,
participants in D-CPT reported more improvement in PTSD
symptomsassessed inclinical interviewsandinself-report than
those receiving WL/TA, with a higher rate of clinically rel-
evant responses. Effect sizes for differences between the 2
interventions were large, with Hedges g values of 0.90 at the
posttreatment and 0.80 at the follow-up assessments. More-
over, participants in D-CPT demonstrated greater improve-
ments inall secondaryoutcomes (depression,borderlinesymp-
tom severity, behavior problems, and dissociation). These
resultsarecomparable toeffect sizes reportedforCPTinadults8
and to overall effect sizes reported inmeta-analyses on PTSD
treatment for childrenandadolescents.11,12Fordepression, ef-
fect sizes of 0.37 (compared with active controls) and 0.60
(comparedwithawait-list condition)were reported,11whereas
we found a large effect size of 0.98 for reduction of depres-
sive symptoms.Wealso founda substantial effect size for bor-
derline symptoms (0.91),whereas a recentmeta-analysiswith
adult samples reportedaneffect sizeof0.35.41EarlyPTSDtreat-
ment might help to prevent borderline symptoms from
becoming chronic.
Fromthepiecewise regression, it becameevident that the
most effective part of D-CPT is the high-intensity CPT phase
starting at themidtreatment assessment. Improvements dur-
ing the first 2 phases of treatment (commitment and emotion
regulation) didnot differ from thoseduringWL/TA.This find-
ing furtherchallenges theneedforastabilizationphaseoremo-
tion regulation training before trauma-focused treatment, at
least in adolescents with abuse-related PTSD (De Jongh and
colleagues42 discuss current recommendations for complex
PTSD in adults).
The only other study we found on treating abuse-related
PTSD in young people did not include an emotion regulation
phase.13However, in this trial by Foa and colleagues,13 prepa-
ratory sessions to address casemanagement issues preceded
randomization, which led to the exclusion of 29 eligible girls.
We decided to randomize all eligible participants for the pur-
pose of generalizability instead. Therefore, when interpret-
ing D-CPT’s dropout rate of 27% (n = 12), one should take into
account that 5 participants were erroneously enrolled; they
had to be referred elsewhere or dropped out when therapeu-
tic focus needed to change. Our results are not directly com-

































Entry Midtreatment Posttreatment 3-mo Follow-up
WL/TA Group
D-CPT Group
Scores for the CAPS-CA range from0 to 136, with higher scores indicating
greater severity of PTSD. D-CPT indicates developmentally adapted cognitive
processing therapy; WL/TA, wait-list/treatment advice.
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abuse, used a different set of outcome measures, evaluated
another trauma-focused treatment (prolongedexposure), and
used a different control condition (supportive counseling).
However, both interventions showed large between-groups
effect sizes for their primary outcomes. In both studies, pre-
treatment toposttreatementdifferences in controlswere sub-
stantial too. This findingmight be especially surprising in our
study, where most WL/TA participants did not receive any
treatment. These findings are in linewith the results of 2other
published Europeanmulticenter trials43,44 that applied simi-
lar methods (eg, CAPS-CA as primary outcome) but targeted
PTSD after miscellaneous trauma in children and adoles-
cents. Effect sizes in control groups were also large (0.88 for
treatment as usual44; 0.88 for waitlist43). Some methodo-
logic issues in these studies (ie, theprospect of receiving treat-
ment after the waiting period, but also extensive preassess-
ment) might encourage more constructive symptom
management.Moreover, inour study, one-thirdofWL/TApar-
ticipants received some kind of professional support, with 8
reporting that the trauma was addressed.
Strengths and Limitations
This RCT has several strengths. It followed a rigorous design,
with the primary outcome assessed in clinical interviews by
blinded raters, andwasperformed inanaturalistic settingwith
14 therapists providing treatment. Unlike most studies in the
field,we extended the participants’ age range to 21 years in ac-
cordance with German health care, where youth as old as 21
years may be treated by child therapists. To permit compari-
sonswithother studies,weprovide results forbothagegroups,
adolescentsvsyoungadults. Limitationsof the trial are the still
rather small and predominantly female (85%) sample. Exclud-
ing participants with recent severe, life-threatening behaviors
and participants with substance dependence with less than 6
monthsof abstinencemight further limit overall generalizabil-
ity. Regarding treatment fidelity ratings, allegiance bias might
be considered. In addition, a 3-month follow-up does not pro-
vide informationon long-termeffects. Finally,when interpret-
ing thebetween-groups effect sizes, theheterogeneousnature
of our control group, which did not control for treatment dos-
age, should be kept in mind. However, recent RCTs reported
similar effect sizes for wait-list and treatment as usual.43,44
Conclusions
Young people with abuse-related PTSD experienced greater
benefit from D-CPT than from WL/TA. This advantage was
stable to the 3-month follow-up. In future studies, disman-
tling designs should be used to further address the question
as to whether emotion regulation training should precede
trauma-focused interventions in this age group.
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